CNSP
Cns Pharmaceuticals Inc

7,858
Mkt Cap
$3.23M
Volume
32.00
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.09
CNSP Fundamentals
Price
$4.55
Prev Close
$5.21
Open
$5.22
50D MA
$6.36
Beta
0.98
Avg. Volume
72,923.95
EPS (Annual)
-$466.44
P/B
0.30
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits·9mo ago
<
...
1
>

Latest CNSP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.